Endo International PLC
NASDAQ:ENDP
Endo International PLC
Cash from Financing Activities
Endo International PLC
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Endo International PLC
NASDAQ:ENDP
|
Cash from Financing Activities
-$513.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Perrigo Company PLC
NYSE:PRGO
|
Cash from Financing Activities
-$187.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Cash from Financing Activities
-$305.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Cash from Financing Activities
$135.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
22%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Cash from Financing Activities
-$204k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Cash from Financing Activities
-€209.3m
|
CAGR 3-Years
-160%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Endo International PLC's Cash from Financing Activities?
Cash from Financing Activities
-513.9m
USD
Based on the financial report for Dec 31, 2022, Endo International PLC's Cash from Financing Activities amounts to -513.9m USD.
What is Endo International PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-387%
Over the last year, the Cash from Financing Activities growth was -387%.